Your browser doesn't support javascript.
loading
Usefulness of neutrophil-to-lymphocyte ratio in predicting progression and survival outcomes after atezolizumab-bevacizumab treatment for hepatocellular carcinoma.
Ochi, Hironori; Kurosaki, Masayuki; Joko, Kouji; Mashiba, Toshie; Tamaki, Nobuharu; Tsuchiya, Kaoru; Marusawa, Hiroyuki; Tada, Toshifumi; Nakamura, Shinichiro; Narita, Ryoichi; Uchida, Yasushi; Akahane, Takehiro; Kondo, Masahiko; Mori, Nami; Takaki, Shintaro; Tsuji, Keiji; Kusakabe, Atsunori; Furuta, Koichiro; Kobashi, Haruhiko; Arai, Hirotaka; Nonogi, Michiko; Tamada, Takashi; Hasebe, Chitomi; Izumi, Namiki.
Afiliación
  • Ochi H; Center for Liver-Biliary-Pancreatic Disease, Matsuyama Red Cross Hospital, Matsuyama, Japan.
  • Kurosaki M; Department of Gastroenterology and Hepatology, Musashino Red Cross Hospital, Musashino, Japan.
  • Joko K; Center for Liver-Biliary-Pancreatic Disease, Matsuyama Red Cross Hospital, Matsuyama, Japan.
  • Mashiba T; Center for Liver-Biliary-Pancreatic Disease, Matsuyama Red Cross Hospital, Matsuyama, Japan.
  • Tamaki N; Department of Gastroenterology and Hepatology, Musashino Red Cross Hospital, Musashino, Japan.
  • Tsuchiya K; Department of Gastroenterology and Hepatology, Musashino Red Cross Hospital, Musashino, Japan.
  • Marusawa H; Department of Gastroenterology and Hepatology, Osaka Red Cross Hospital, Osaka, Japan.
  • Tada T; Department of Internal Medicine, Himeji Red Cross Hospital, Himeji, Japan.
  • Nakamura S; Department of Internal Medicine, Himeji Red Cross Hospital, Himeji, Japan.
  • Narita R; Department of Gastroenterology, Oita Red Cross Hospital, Oita, Japan.
  • Uchida Y; Department of Gastroenterology, Matsue Red Cross Hospital, Matsue, Japan.
  • Akahane T; Department of Gastroenterology, Ishinomaki Red Cross Hospital, Ishinomaki, Japan.
  • Kondo M; Department of Gastroenterology, Otsu Red Cross Hospital, Otsu, Japan.
  • Mori N; Department of Gastroenterology, Hiroshima Red Cross Hospital and Atomic-bomb Survivors Hospital, Hiroshima, Japan.
  • Takaki S; Department of Gastroenterology, Hiroshima Red Cross Hospital and Atomic-bomb Survivors Hospital, Hiroshima, Japan.
  • Tsuji K; Department of Gastroenterology, Hiroshima Red Cross Hospital and Atomic-bomb Survivors Hospital, Hiroshima, Japan.
  • Kusakabe A; Department of Gastroenterology, Japanese Red Cross Nagoya Daini Hospital, Nagoya, Japan.
  • Furuta K; Department of Gastroenterology, Masuda Red Cross Hospital, Masuda, Japan.
  • Kobashi H; Department of Gastroenterology, Japanese Red Cross Okayama Hospital, Okayama, Japan.
  • Arai H; Department of Gastroenterology, Maebashi Red Cross Hospital, Maebashi, Japan.
  • Nonogi M; Department of Gastroenterology, Tokushima Red Cross Hospital, Komatsushima, Japan.
  • Tamada T; Department of Gastroenterology, Takatsuki Red Cross Hospital, Takatsuki, Japan.
  • Hasebe C; Department of Gastroenterology, Japanese Red Cross Asahikawa Hospital, Asahikawa, Japan.
  • Izumi N; Department of Gastroenterology and Hepatology, Musashino Red Cross Hospital, Musashino, Japan.
Hepatol Res ; 53(1): 61-71, 2023 Jan.
Article en En | MEDLINE | ID: mdl-36070216
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Hepatol Res Año: 2023 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Países Bajos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Hepatol Res Año: 2023 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Países Bajos